StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — Kush Bohra

BUYGlaxoSmithKline Pharmaceuticals Limited

byKush BohraHorizon: NA (inferred Swing (≤2wk))23 Jul 2026via NDTV Profit

Entry₹2,552.8Inferred
Target₹2,725
Total upside +6.75% (call closed)
Stop loss₹2,470-3.24% risk
Exit₹2,47024 Jul 2026, 10:00 am
Stop-loss hit-3.24%
Follow Kush Bohra for new calls(39% target hit, 84 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Jul 2026
3 supporting0 opposing
Supports the BUY call (3)

Nestle, GSK Pharma Show Momentum as Market Faces Pressure

NewsGoogle News·23 Jul · yesterday

(opens in new tab)

Nestle, GSK Pharma में तेजी के संकेत, गिरावट में बाजार

NewsGoogle News·23 Jul · yesterday

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Jul · 2d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.